AS-1411
N/A
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameAS-1411
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alabama At BirminghamUniversity Of LouisvilleAntisoma
China Registration ClassN/A
Develop Information
Active CompaniesUofl Health - James Graham Brown Cancer CenterUniversity Of LouisvilleAdvanced Cancer Therapeutics Llc +[5]
Inactive CompaniesAntisoma Research Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A